CPD module: Pharmacogenomics

After completing this module, you should be more aware of:

• What pharmacogenomics means and how it fits in with genomic medicine
• NHS and other bodies involved in developing and rolling out genomic testing
• The implications for pharmacogenomics under the NHS Long Term Plan
• The concept of personalised or precision medicine
• The National Genomic Medicine Service for England
• The impact of drug effectiveness and adverse drug reactions on the NHS
• The human genome and the extent and significance of genetic variation
• The difference between genotype and phenotype and how this is used in genomic medicine testing
• Significant gene types and how they affect medicines uptake, effect and metabolism
• Different modes of pharmacogenomic activity with examples for common medicines.